125 related articles for article (PubMed ID: 1946543)
41. Mode of action considerations in the quantitative assessment of tumour responses in the liver.
Boobis AR
Basic Clin Pharmacol Toxicol; 2010 Mar; 106(3):173-9. PubMed ID: 20030633
[TBL] [Abstract][Full Text] [Related]
42. Mechanisms of non-genotoxic carcinogenesis.
Shaw IC; Jones HB
Trends Pharmacol Sci; 1994 Mar; 15(3):89-93. PubMed ID: 8184492
[TBL] [Abstract][Full Text] [Related]
43. Risk extrapolation for chlorinated methanes as promoters vs initiators of multistage carcinogenesis.
Bogen KT
Fundam Appl Toxicol; 1990 Oct; 15(3):536-57. PubMed ID: 2258018
[TBL] [Abstract][Full Text] [Related]
44. Response to Tollefson et al.
Hearne FT
Risk Anal; 1991 Dec; 11(4):569-74. PubMed ID: 1780497
[No Abstract] [Full Text] [Related]
45. Cell proliferation and cell death in rat liver carcinogenesis by chemicals.
Ledda-Columbano GM; Coni P; Columbano A
Arch Toxicol Suppl; 1994; 16():271-80. PubMed ID: 8192590
[No Abstract] [Full Text] [Related]
46. Does chemically induced hepatocyte proliferation predict liver carcinogenesis?
Melnick RL
FASEB J; 1992 Jun; 6(9):2698-706. PubMed ID: 1612294
[TBL] [Abstract][Full Text] [Related]
47. Cell proliferation and chemical carcinogenesis: symposium overview.
Melnick RL; Huff J; Barrett JC; Maronpot RR; Lucier G; Portier CJ
Environ Health Perspect; 1993 Dec; 101 Suppl 5(Suppl 5):3-7. PubMed ID: 7912189
[TBL] [Abstract][Full Text] [Related]
48. Hepatocarcinogenesis by chemicals.
Miller EC; Miller JA
Prog Liver Dis; 1976; 5():699-711. PubMed ID: 775563
[No Abstract] [Full Text] [Related]
49. From exposure to effect: a comparison of modeling approaches to chemical carcinogenesis.
van Leeuwen IM; Zonneveld C
Mutat Res; 2001 Oct; 489(1):17-45. PubMed ID: 11673088
[TBL] [Abstract][Full Text] [Related]
50. Mechanisms of susceptibility to mouse liver carcinogenesis.
Dragan Y; Klaunig J; Maronpot R; Goldsworthy T
Toxicol Sci; 1998 Jan; 41(1):3-7. PubMed ID: 9520336
[No Abstract] [Full Text] [Related]
51. Use of cell proliferation data in cancer risk assessment: FDA view.
Scheuplein RJ
Environ Health Perspect; 1993 Dec; 101 Suppl 5(Suppl 5):139-41. PubMed ID: 8013401
[TBL] [Abstract][Full Text] [Related]
52. Using cell replication data in mathematical modeling in carcinogenesis.
Portier CJ; Kopp-Schneider A; Sherman CD
Environ Health Perspect; 1993 Dec; 101 Suppl 5(Suppl 5):79-86. PubMed ID: 8013428
[TBL] [Abstract][Full Text] [Related]
53. Chemically induced cell proliferation. Implications for risk assessment. Proceedings of the Chemically Induced Cell Proliferation Conference. Austin, Texas, November 29-December 2, 1989.
Prog Clin Biol Res; 1991; 369():1-532. PubMed ID: 1682944
[No Abstract] [Full Text] [Related]
54. Chemicals: perceptions versus facts.
Abelson PH
Science; 1994 Apr; 264(5156):183. PubMed ID: 8146641
[No Abstract] [Full Text] [Related]
55. Liver carcinogenesis: the role for some chemicals of an epigenetic mechanism of liver-tumour promotion involving modification of the cell membrane.
Williams GM
Food Cosmet Toxicol; 1981 Oct; 19(5):577-83. PubMed ID: 7308903
[No Abstract] [Full Text] [Related]
56. The sequential analysis of cancer induction with chemicals.
Farber E
Acta Pathol Jpn; 1981 Jan; 31(1):1-11. PubMed ID: 7234414
[TBL] [Abstract][Full Text] [Related]
57. Cell Proliferation and Chemical Carcinogenesis. Symposium proceedings. Triangle Park, North Carolina, January 14-16, 1992.
Environ Health Perspect; 1993 Dec; 101 Suppl 5():1-302. PubMed ID: 7912185
[No Abstract] [Full Text] [Related]
58. Mitogenesis is only one factor in carcinogenesis.
Weinstein IB
Science; 1991 Jan; 251(4992):387-8. PubMed ID: 1989073
[No Abstract] [Full Text] [Related]
59. Early biological markers during liver carcinogenesis.
Bannasch P; Hacker HJ; Mayer D
Arch Toxicol Suppl; 1979; (2):145-55. PubMed ID: 88928
[No Abstract] [Full Text] [Related]
60. Carcinogens.
Cohen SM; Ellwein LB
Lancet; 1991 Apr; 337(8747):973. PubMed ID: 1678046
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
